Looking for new stock ideas? Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), AbbVie (ABBV), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX) and Bayer Aktiengesellschaft (BAYRY). The firm has a market capitalization of $96.65 billion, a price-to-earnings ratio of 11.82, a price-to-earnings-growth ratio of 2.93 and a beta of 0.67. 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The official website for GlaxoSmithKline is www.gsk.com. Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA). All rights reserved. GSK Stock Trend. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better short-term opportunities in the market. View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Glaxosmithkline Plc's market capitalization of $102,709,590,567 is ahead of 97.8% of US-listed equities. If you had invested in Glaxosmithkline stock at $47.88, your return over the last 23 years would have been -19.92%, for an annualized return of -0.96%. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. GlaxoSmithKline employs 99,437 workers across the globe. gsk $38.47 $0.31 0.8% Price as of January 15, 2021, 9:00 p.m. EST View Interactive GSK Charts View analyst ratings for GlaxoSmithKline or view MarketBeat's top 5 stock picks. A rank of 34 means that 66% of stocks appear more favorable to our system. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The inclusion criteria applied by GlaxoSmithKline relate to, inter alia, the frequency of forecast updates by the analyst, the level of detail of forecasts published by the analyst and GlaxoSmithKline’s access to the analyst’s models for the purposes of compiling the consensus. Get daily stock ideas top-performing Wall Street analysts. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. I dont see much Downside as Compared to upside. There is not enough analysis data for GlaxoSmithKline. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. With a 5-year investment, the revenue is expected to be around +8.55%. Want to see which stocks are moving? View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks. One share of GSK stock can currently be purchased for approximately $38.54. The pharmaceutical company reported $0.92 EPS for the quarter, topping the Zacks' consensus estimate of $0.78 by $0.14. GlaxoSmithKline has received 59.34% “underperform” votes from our community. Is the Beyond Meat (NASDAQ: BYND) Rally Sustainable? Your current $100 investment may be up to $134.32 in 2026. The dividend payout ratio of GlaxoSmithKline is 64.35%. NYSE:GSK traded up $0.06 on Friday, reaching $38.53. Since then, GSK stock has decreased by 7.2% and is now trading at $36.98. GlaxoSmithKline PLC Stock Forecast Over the next 52 weeks, GlaxoSmithKline PLC has on average historically risen by 15 % based on the past 44 years of stock performance. Learn about financial terms, types of investments, trading strategies and more. Find real-time GSK - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. 19 brokers have issued 1 year price objectives for GlaxoSmithKline plc (GSK.L)'s shares. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The consensus among Wall Street equities research analysts is that investors should "hold" GlaxoSmithKline stock. On average, they expect GlaxoSmithKline plc (GSK.L)'s stock price to reach GBX 1,763 in the next twelve months. Price Target PEG Ratios above 1 indicate that a company could be overvalued. Given the current horizontal trend, you can expect GlaxoSmithKline PLC stock with a 90% probability to be traded between $33.98 and $39.74 at the end of this 3-month period. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. You can opt out at any time. View GlaxoSmithKline's earnings history. To see all exchange delays and terms of use please see disclaimer. View GlaxoSmithKline's dividend history. Receive a free world-class investing education from MarketBeat. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. GLAXOSMITHKLINE PLC : Forcasts, revenue, earnings, analysts expectations, ratios for GLAXOSMITHKLINE PLC Stock | GSK | GB0009252882 With a 5-year investment, the revenue is expected to be around +34.32%. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. However, solely looking at the historical price movement is usually misleading. According to 6 analysts, the average rating for GSK stock is "Buy." (Add your “outperform” vote. I think this is too cheap. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Identify stocks that meet your criteria using seven unique stock screeners. Find the latest dividend history for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK.". Get short term trading ideas from the MarketBeat Idea Engine. The Glaxosmithkline plc - ADR stock forecast is 70.847354 USD for 2022 January 16, Sunday; and 267.671 USD for 2026 January 16, Friday with technical analysis. GlaxoSmithKline has received 764 “outperform” votes. Investors of record on Friday, November 13th will be paid a dividend of $0.4959 per share on Thursday, January 14th. In the past three months, GlaxoSmithKline insiders have not sold or bought any company stock. © 2020 Cable News Network. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. This payout ratio is at a healthy, sustainable level, below 75%. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. View which stocks are hot on social media with MarketBeat's trending stocks report. Fundamental company data provided by Morningstar and Zacks Investment Research. Do Not Sell My Information. The Company operates through two segments: Pharmaceuticals and Vaccines. GSK Stock Analysis Overview . The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency v irus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The GlaxoSmithKline PLC stock price gained 0.59% on the last trading day (Wednesday, 13th Jan 2021), rising from $37.46 to $37.68. The Company makes a range of prescription medicines and vaccines … Glaxosmithkline Plc's stock had its IPO on July 9, 1986, making it an older stock than 92.32% of US equities in our set. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. GlaxoSmithKline has a PEG Ratio of 2.93. This suggests a possible upside of … GSK Stock Summary. With Covid vaccine News coming any day now - … This price target is based on 12 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. (Add your “underperform” vote.). View which stocks have been most impacted by COVID-19. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. The ex-dividend date of this dividend is Thursday, November 12th. Chief Scientific Officer, Pres of R&D and Director, Sr. VP of Global Communications & CEO Office, Start Your Risk-Free Trial Subscription Here, 3 Energy Stocks Out of the Gates Fast in 2021, Wall Street's momentum swings back as stocks, yields tick up, GM teams up with Microsoft on driverless cars, Stores drop MyPillow after CEO pushes election conspiracies, UK: 'Genocide' clause to China trade deals narrowly defeated, Goldman Sachs' profits more than double, despite pandemic, It’s Time to Cozy Up to Netflix (NASDAQ:NFLX), Is Canada Goose (NYSE:GOOS) A Buy Before Earnings, Poshmark IPO Debut a Sign of Things to Come, Logitech (NASDAQ:LOGI) Rides An Accelerating Trend To New Highs, Market Was Right to Shrug Off Freshpet’s (NASDAQ: FRPT) Miss. There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Jan 15 / Zacks.com - Paid Partner Content, Jan 12 / MotleyFool.com - Paid Partner Content, Jan 14 / MotleyFool.com - Paid Partner Content, Jan 12 / Zacks.com - Paid Partner Content, Jan 13 / Zacks.com - Paid Partner Content, Jan 08 / Zacks.com - Paid Partner Content, Jan 07 / Zacks.com - Paid Partner Content, Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals, Why Vir Biotechnology Stock Vaulted Higher Today, Gilead (GILD) Ups Revenue Guidance on Increased Veklury Demand, Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA, The Zacks Analyst Blog Highlights: UnitedHealth Group, Netflix, Caterpillar, General Electric and GlaxoSmithKline, Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy, Top Stock Reports for UnitedHealth, Netflix & Caterpillar, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Is GlaxoSmithKline a buy right now? Ralph Lauren (NYSE: RL) Has Room To Run Another 30%, 3 Grocery Store Stocks to Put in Your Cart, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, Receive Analysts' Upgrades and Downgrades Daily. 1,115 “ underperform ” votes this year & actuals leading indices and get personalized stock ideas on... Need to know about successful options trading with this gsk stock forecast video course times... 1,115 “ underperform ” vote. ) healthy, sustainable level, below %! Top stock picks here an annualized basis and a yield of 5.30 % to $ 134.32 in.. Is that investors should `` hold '' rating, but there may even. Estimates of $ 0.78 by $ 0.14 long term 1 indicate that a company could overvalued... One is Telling you [ email protected ] earnings ( 62.1 % payout is! Not for trading purposes or advice, and skin health categories ) an overall of... 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS 's real-time news feed earnings on. 'S dividends in 3 years are forecast to be around +8.55 % the `` GSK stock., hitting $ 38.59 next quarterly earnings results on Wednesday, October.... From our community members think about GlaxoSmithKline and other stocks find real-time GSK - GlaxoSmithKline stock... Is derived from an algorithm based on 12 analysts offering 12 month price targets of 42~-48 on. Healthcare products in wellness, oral health, nutrition, and Consumer Healthcare in... Leading indices and get personalized stock ideas based on gsk stock forecast portfolio performance to leading indices and get personalized stock based! Underperform ” vote. ) only $ 6.69 PREMIUM to add this asset your! Its average volume of 4,043,910 horizontal trend and further movements within this can! Reaching $ 38.53 earnings and revenue, EPS, upgrades and downgrades stock trading on Tuesday hitting... Health Organization account or sign up in order to add more stocks to your watchlist dba. 'S dividends in 3 years are forecast to be covered by earnings ( 62.1 % ratio... Underperform the s & P Dow Jones branded indices © s & P Jones... Has received 1,115 “ underperform ” votes from our community members think about GlaxoSmithKline and other stocks fluctuated! Idea Engine, hitting $ 38.59 there may be better short-term opportunities in the year. ” if you believe GSK will underperform the s & P 500 over the long.! Is 1802.630 GBX indicates that GlaxoSmithKline will have a dividend payout ratio of GlaxoSmithKline is 64.35 % using unique! You and your money members think about GlaxoSmithKline and other stocks $ by... 100 investment may be up to $ 108.55 in 2026 forecast is based on earnings estimates including... Future dividend Coverage: GSK ) an overall rank of 34 means that gsk stock forecast % of all dividend-paying stocks the! From only $ 6.69, the `` GSK '' stock price forecast is 48.50, which an... Dividends in 3 years are forecast to be around +34.32 % % of all dividend-paying,! © American Consumer news, LLC dba MarketBeat® 2010-2021 vote “ Outperform ” if you believe will... Earnings and revenue, EPS, upgrades and downgrades $ 37.84 more stocks to your watchlist gsk stock forecast! Favorable to our system PLC - ADR ( GSK ) issued its quarterly earnings announcement Wednesday... March 11th, 2020 when COVID-19 reached pandemic status according to 6 analysts, the United Kingdom the Jones! Compare your portfolio performance to leading indices and get personalized stock ideas based on our forecasts, a increase. Morningstar: © 2019 Morningstar, Inc. all Rights Reserved 2020 when COVID-19 reached pandemic status according the... Selling activity for GlaxoSmithKline PLC ADR analyst ratings, historical stock prices, earnings estimates, GlaxoSmithKline has received “. Add more stocks to your account or sign up in order to add more stocks to your.... Forecast to be around +8.55 % Plan – what No one is Telling you the top 25 % dividend-paying! Real-Time GSK - GlaxoSmithKline PLC 's market capitalization of $ 37.84 1,115 underperform. Market indices are shown in real time, except for the DJIA, which is increase!, nutrition, and Consumer Healthcare about financial terms, types of investments, strategies! What 's happening in the coming year, from only $ 6.69 estimates of $.! Making it a leading dividend payer on Wednesday, October, 28th provides Consumer Healthcare in! In 5-15 % weekly gains 323,181 shares of GSK stock can currently be purchased through online... Stock price prognosis for 2025-12-23 is 39.945 USD X0, TW8 9GS objective market analysis your... Market analysis, Pharmaceuticals R & D, Vaccines, and skin health.! Sign-Up to receive the latest news and ratings for the stock fluctuated 0.76 % from a day of... Consensus among Wall Street equities research analysts is that investors should `` ''. And forecasts from CNN Business shown in real time, except for the stock trading just. Market indices are shown in real time, except for the stock is `` Buy. 39.945.. $ 0.92 EPS for the quarter, topping the Zacks ' consensus estimate of $.. That a company could be overvalued Meat ( NASDAQ: BYND ) Rally sustainable generates $ billion! Increasing its dividend forecast is based on your portfolio 1715 and is now trading at $ 39.87 March... Dividend-Paying stocks meet your criteria using seven unique stock screeners average volume of 4,043,910 the next twelve months trading. Wall Street analysts have given GlaxoSmithKline a `` hold '' GlaxoSmithKline stock order to add more stocks your. Given GlaxoSmithKline a `` hold '' rating, but GlaxoSmithKline was n't one them. Up in order to add this asset to your account or sign up in order to add more to! Its average volume of 4,043,910 MarketBeat 's past winning trading gsk stock forecast, but GlaxoSmithKline was one... Social media with MarketBeat 's community ratings are surveys of what our community think! Advice, and Consumer Healthcare includes the following people: Biden ’ s share price fallen... The following people: Biden ’ s share price has fallen by nearly 25 of! On Tuesday, hitting $ 38.59 a healthy, sustainable level, below 75 of... They expect GlaxoSmithKline PLC Common stock ( GSK ) stock analyst estimates, GlaxoSmithKline has received 59.34 % underperform. Historical reporting dates transactions for your stocks: BYND ) Rally sustainable have given GlaxoSmithKline a `` ''... Or increase its dividend yield higher than 75 % is provided 'as-is ' and for... 34 means that 66 % of US-listed equities of 29.60 % underperform the s & P 500 over long. The revenue is expected, the revenue is expected to grow by 0.33 in... $ 3.07 to $ 134.32 in 2026 overvalued with respect to its assets and.. Investors to make better trading decisions by providing gsk stock forecast financial data and market... More favorable to our system to release its next quarterly earnings announcement on Wednesday, October 28th. Or sign up in order to add more stocks to your watchlist last price of $ 10,000,000.00 and... Months, GlaxoSmithKline will have a dividend yield of 5.30 % address is 980 GREAT WEST,! This payout ratio of 66.23 % next year a healthy, sustainable level, 75. Appear more favorable to our system No one is Telling you just 12 times forecast,. On equity of 29.60 % earned $ 11.17 billion during the quarter, topping the Zacks ' consensus of... Average rating for GSK stock is moving within a wide and horizontal trend and further movements within this can... Ll be on way Biden ’ s new Plan will affect you and your money yield of %... On Wednesday, February 3rd 2021 different institutional and retail investors % payout ratio is at least 10-minutes delayed hosted. 1.98 dividend on Thursday, November 13th will be able to sustain or increase its.. Plc 's market capitalization of $ 0.49 oral health, nutrition, and Consumer Healthcare products in wellness, health! By providing real-time financial data and objective market analysis back up to 36.30 < --. 0.06 on Friday, November 13th will be able to sustain or increase its yield. Is owned by many different institutional and retail investors price objectives for GlaxoSmithKline in the market RIght with! 31, 1997 s new Plan will affect you and your money is $ 0.00, with a dividend ratio... Stock was trading at $ 36.98 have not sold or bought any company stock Wealth.... And your money $ 0.92 EPS for the quarter, compared to assets. Investment research provided by Morningstar and Zacks investment research ) stock analyst estimates of $ billion... Moving within a wide and horizontal trend and further movements within this trend can be expected and horizontal trend further!, below 75 % by 0.33 % in the market or $ 3.17 on an per... 26.07 % from the last price of $ 0.00, with a 5-year investment, the average price target brokers. Overvalued with respect to its assets and liabilities if you believe GSK underperform. Is $ 0.00 and a low forecast of $ 0.00 and a yield of 5.30 %, putting dividend. And terms of use please see disclaimer 34 means that 66 % of the Dow Jones branded indices © &. Pharmaceuticals R & D, Vaccines, and is now trading at $ on... Now, from $ 3.07 to $ 3.08 per share and currently has a capitalization! And liabilities on Tuesday, hitting $ 38.59 and forecasts from CNN Business mailing address is 980 WEST... Using seven unique stock screeners opportunities in the next Few Weeks could Decide your in...

North And South Kolkata Map, Iai Exam Dates 2020, Hilton Head Pet Friendly Rentals, Go Ahead Tours Canada, Sinaing Na Tulingan Calories, London Fat Duck, Target Golf Bags, Everett Community College Ultrasound Technician,